Both sexes are subject to the neurochemical effects on reward pathways, but hormonal factors create different clinical presentations
Yoon (2006) In: Akoh CC (ed) Handbook of functional lipids
Beyond Concierge Healthcare brings concierge medical care to you
J Psychoactive Drugs 2011;43(1):1-5
Compared with SGLT2i alone, combination therapy was significantly associated with 42% lower risk of ischemic stroke, 37% lower risk of MI, 46% lower risk of 3-point MACE, and 45% lower risk of 5-point MACE among people with T2D and ASCVD
Searches were conducted using combinations of keywords and Medical Subject Headings (MeSH) terms related to incretin-based therapies and obesity, including GLP-1 receptor agonists, dual agonists, triple agonists, liraglutide, semaglutide, tirzepatide, mazdutide, retatrutide, adolescent obesity, and pediatric obesity